Biogen Inc. buy Wells Fargo & Company
Start price
07.08.23
/
50%
€244.00
Target price
07.08.24
€311.86
Performance (%)
-25.51%
End price
08.08.24
€181.75
Summary
This prediction ended on 08.08.24 with a price of €181.75. The prediction for Biogen Inc. disappointed with a performance of -25.51%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -7.266% | -7.266% | 27.107% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Wells Fargo & Company from $350.00 to $343.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten